JPMorgan Chase & Co’s Skye Bioscience SKYE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-9,904
Closed -$15.7K 6695
2025
Q1
$15.7K Buy
9,904
+653
+7% +$1.04K ﹤0.01% 5347
2024
Q4
$26.2K Sell
9,251
-2,111
-19% -$5.97K ﹤0.01% 5169
2024
Q3
$44.4K Sell
11,362
-3,609
-24% -$14.1K ﹤0.01% 5020
2024
Q2
$120K Buy
+14,971
New +$120K ﹤0.01% 4519